These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000615-99 Freiburger ZNS-NHL Studie Therapie für Patienten mit primären Non-Hodgkin Lymphomen des ZNS – Sequentielle Hochdosis-Chemotherapie mit autologer peripherer Blutstammzelltransplantation 2015-03-02 due-trials
Not reported 2005-000663-26 Immunsuppressive Therapy in Duchenne Muscular Dystrophy 2008-04-30 due-trials
Not reported 2005-003812-31 Niaspan in combination with fluvastatin compared to fluvastatin-monotherapy fpr patients with metabolic syndrome 2009-02-27 due-trials
Ongoing 2006-000222-31 Vergleich einer strukturierten störungsspezifischen Gruppenpsychotherapie plus Placebo oder Methylphenidat versus einer psychiatrischen Beratung plus Placebo oder Methylphenidat bei ADHS im Erwachsen... not-yet-due
Not reported 2006-002207-13 Ziprasidone for severe conduct and other disruptive behavior disorders in children and adolescents – a placebo controlled, randomized, double blind clinical trial 2009-12-21 due-trials
Not reported 2006-005906-30 The effect of Ezetimibe 10 mg, Simvastatin 20 mg and the Combination of Simvastatin 20 mg plus 10 mg Ezetimibe on LDL-Subfractions in patients with Type 2 Diabetes (Die Wirkung einer Monotherapie mit ... 2010-05-19 due-trials
Ongoing 2007-001892-12 Everolimus and mycophenolate as GvHD-prophylaxis in the allogenous blood stem cell transplantation (Everolimus und Mycophenolsäure als GvHD-Prophylaxe in der allogenen Blutstammzelltransplantation) not-yet-due
Ongoing 2007-004990-24 Comparison of the concentrations of the antibiotic compound Daptomycin in serum, cartilage-, muscle and subcutaneous tissue after a preoperative intravenous administration not-yet-due
Not reported 2007-006516-31 Triple arm, prospective-randomised multi centre study phase IV to evaluate calcineurin inhibitor reduced, steroid free immunosuppression after renal transplantation in low-risk patients (HARMONY-Study... 2014-07-31 due-trials
Ongoing 2007-006914-41 Differential responses to Cognitive Behavioural Analysis System of Psychotherapy (CBASP) versus escitalopram in chronic major depression with and without early trauma not-yet-due
Not reported 2008-001833-87 Use of Palifermin to reduce the duration, frequency and severity of oral mucositis after high dose therapy with BEAM and autologous peripheral blood stem cell transplantation in patients with malign l... 2011-06-30 due-trials
Not reported 2008-007645-31 Freiburger Studie zur Behandlung von Primären ZNS-Lymphomen bei Patienten über 65 Jahre: Methotrexat-basierte Chemo-Immuntherapie mit anschließender Erhaltungstherapie - PRIMAIN-Studie - 2015-03-02 due-trials
Completed, but no date 2009-009916-33 Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic ac... bad-data
Ongoing 2009-012432-32 Randomised phase II trial on primary chemotherapy with high-dose Methotrexate and high-dose Cytarabine with or without Thiotepa, and with or without Rituximab, followed by brain irradiation vs high-do... not-yet-due
Not reported 2010-018624-20 Tolerance of virucidal alcohol-based hand rubs - healthy volunteer trial 2011-01-17 due-trials
Ongoing 2010-020956-69 Effekte von Oxytocin bei Patientinnen und Patienten mit Borderline-Persönlichkeitsstörung not-yet-due
Ongoing 2010-022511-18 Behavioral effects and neural correlates of oxytocin on social attention [Verhaltenseffekte und neuronales Korrelat von Oxytocin im Kontext sozialer Aufmerksamkeit] not-yet-due
Completed, report not yet due 2011-000388-28 Safety of Vorinostat in combination with Bortezomib, Doxorubicin and Dexamethasone (VBDD) in patients with refractory or relapsed multiple myeloma 2015-12-01 not-yet-due
Ongoing 2012-003281-40 Efficacy of gencydo nasal spray on early nasal response after allergen exposition in patients with grass pollen allergy: a randomized, placebo controlled cross over study not-yet-due
Ongoing 2012-005414-18 Thiotepa- Fludarabine- Treosulfan (TFT) conditioning for 2nd allogeneic PBSCT from a different unrelated donor in patients with AML relapsing from prior allogeneic HCT not-yet-due
Completed, report not yet due 2013-000077-68 Imatinib continuation versus Nilotinib 300 mg twice daily in patients with chronic myeloid leukemia (CML) in chronic phase and major molecular response (MMR) without molecular response ≥ 4.5 log (MR4.... 2018-09-18 not-yet-due
Ongoing 2013-002515-10 Treatment of Optic Neuritis with Erythropoietin: a randomised, double-blind, placebo-controlled trial not-yet-due
Ongoing 2013-002539-13 Multicenter randomized double masked parallel design exploratory study to assess safety and efficacy of two different doses of intravitreal anti-VEGF treatment with ranibizumab (0.12 mg vs. 0.20 mg) i... not-yet-due
Not reported 2013-004879-13 α-RT; Phase II open-label study to evaluate the efficacy and safety of Radium-223 dichloride in combination with external beam radiotherapy (EBRT) vs. EBRT alone in the treatment of advanced castrati... 2017-05-30 due-trials
Not reported 2014-000180-41 Carriage of 3GCREB in patients at risk for relapsing infection: randomized controlled trial of intestinal decolonization with colistin plus rifaximin. 2016-12-02 due-trials
Ongoing 2014-001148-40 Pharmacodynamic comparison of thienopyridine loading strategies in patients undergoing elective coronary stenting not-yet-due
Ongoing 2014-001541-24 Neuroenhancement of Interpersonal Psychotherapy in Major Depression not-yet-due
Ongoing 2014-004267-20 Multicenter, randomized Phase 2 Trial to determine the Response Rate of Ruxolitinib and Best Available Treatment (BAT) versus BAT in Steroid-refractory acute Graft-versus-Host Disease (aGvHD) not-yet-due
Ongoing 2014-005069-60 R-CPOP as first line therapy for elderly patients with DLBCL and for patients with limited cardiac function with DLBCL not-yet-due
Ongoing 2014-005473-36 Modeling of lipoprotein in patients with familial hypercholesterolemia compared to healthy subjects not-yet-due
Ongoing 2015-001683-20 Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus not-yet-due
Completed, report not yet due 2015-002491-24 Safety of Abatacept in patients with interstitial lung disease and common variable immunodeficiency (CVID) and related disease 2018-09-26 not-yet-due
Completed, report not yet due 2015-003369-27 A Phase I-IIa trial on low-dose IL-2 (Aldesleukin) treatment for immunological dysregulation in common variable immunodeficiency (CVID) 2018-06-05 not-yet-due
Ongoing 2015-003670-32 A dual-center prospective phase I/II trial to establish safety, tolerability and to obtain first data on efficacy of losartan in children with recessive dystrophic epidermolysis bullosa (RDEB) not-yet-due
Ongoing 2015-005071-25 Pharmacodynamic comparison of different oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor in patients undergoing coronary stenting not-yet-due
Ongoing 2016-000214-30 Empagliflozin and its effect on heart failure in type 2 diabetes not-yet-due
Ongoing 2016-001628-72 Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients not-yet-due
Ongoing 2016-003360-39 Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis not-yet-due
Ongoing 2017-002194-18 Phase 1/2 Trial to determine the Response Rate of Nivolumab in Acute Myeloid Leukemia (AML) relapse after Allogeneic Hematopoietic Cell Transplantation (allo-HCT) not-yet-due
Ongoing 2018-000017-20 Impact of dipyrone (metamizole) on the antiplatelet effect of aspirin in patients after bioprosthetic aortic valve replacement not-yet-due